FimAsartaN proTeinuriA SusTaIned reduCtion in Comparison With Losartan in Diabetic Chronic Kidney Disease (FANTASTIC): Study Protocol for Randomized Controlled Trial

Trials - United Kingdom
doi 10.1186/s13063-017-2375-8
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Randomized Controlled Trial of Exercise in Chronic Kidney Disease - The RENEXC Study

Kidney International Reports
Nephrology
2019English

Wellbeing Intervention for Chronic Kidney Disease (WICKD): A Randomised Controlled Trial Study Protocol

BMC psychology
MedicinePsychology
2019English

Chinese Herbal Medicine Tangshen Formula Treatment for Type 2 Diabetic Kidney Disease in the Early Stage: Study Protocol for a Randomized Controlled Trial

Trials
MedicinePharmacology
2019English

Atorvastatin Improves Tubular Status in Non-Diabetic Patients With Chronic Kidney Disease - Placebo Controlled, Randomized, Cross-Over Study.

Acta Biochimica Polonica
BiochemistryGeneticsMolecular Biology
2010English

Efficacy of Tuina in Patients With Chronic Low Back Pain: Study Protocol for a Randomized Controlled Trial

Trials
MedicinePharmacology
2020English

Yinang Formulation Versus Placebo Granules as a Treatment for Chronic Kidney Disease Stages III–IV in Patients With Autosomal Dominant Polycystic Kidney Disease: Study Protocol for a Double-Blind Placebo-Controlled Randomized Clinical Trial

Trials
MedicinePharmacology
2019English

Virtual House Calls for Parkinson Disease (Connect.Parkinson): Study Protocol for a Randomized, Controlled Trial

Trials
MedicinePharmacology
2014English

Effectiveness and Cost-Effectiveness of Telehealthcare for Chronic Obstructive Pulmonary Disease: Study Protocol for a Cluster Randomized Controlled Trial

Trials
MedicinePharmacology
2014English

Effect of Combining Losartan and Perindopril in Diabetic Patients With Proteinuria

Asian Journal of Pharmaceutical and Clinical Research
PharmacologyPharmaceutical Science
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy